Physician profile
Michael Wolinski
NPI 1013776673
$1,607.93
in general payments reported to CMS, 2019-2025
14 companies · $1,163 in 2025
The $1,163 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $445 · 2025: $1,163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,608.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,607.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $371.69 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $346.30 | 2024-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $204.50 | 2024-2025 | Farxiga, Wainua |
| Pfizer INC. | $141.21 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $140.75 | 2024-2025 | Eliquis, Camzyos |
| Novo Nordisk INC | $120.19 | 2025 | Wegovy |
| Alnylam Pharmaceuticals INC. | $78.98 | 2024-2025 | Onpattro |
| Janssen Pharmaceuticals, INC | $61.96 | 2025 | Opsynvi, Uptravi |
| Abiomed | $33.46 | 2024 | Impella |
| Bayer Healthcare Pharmaceuticals INC. | $30.58 | 2025 | |
| Ionis Pharmaceuticals, INC. | $23.77 | 2025 | Tryngolza |
| Vital Connect, INC | $20.56 | 2025 | Vitalpatch Rtm |
| Lantheus Medical Imaging, INC. | $18.86 | 2025 | |
| Medtronic, INC. | $15.12 | 2025 | Corevalve Evolut R |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wolinski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.